Literature DB >> 11859838

High serum S100B levels for trauma patients without head injuries.

B Romner, T Ingebrigtsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11859838     DOI： 10.1097/00006123-200112000-00053

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  13 in total

Review 1.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

Review 2.  Expert consensus document: Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions.

Authors:  Aaron J Carman; Rennie Ferguson; Robert Cantu; R Dawn Comstock; Penny A Dacks; Steven T DeKosky; Sam Gandy; James Gilbert; Chad Gilliland; Gerard Gioia; Christopher Giza; Michael Greicius; Brian Hainline; Ronald L Hayes; James Hendrix; Barry Jordan; James Kovach; Rachel F Lane; Rebekah Mannix; Thomas Murray; Tad Seifert; Diana W Shineman; Eric Warren; Elisabeth Wilde; Huntington Willard; Howard M Fillit
Journal:  Nat Rev Neurol       Date:  2015-03-17       Impact factor: 42.937

Review 3.  Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood.

Authors:  Henrik Zetterberg; Douglas H Smith; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2013-02-12       Impact factor: 42.937

4.  S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury.

Authors:  Valentina Di Pietro; Angela Maria Amorini; Giacomo Lazzarino; Kamal Makram Yakoub; Serafina D'Urso; Giuseppe Lazzarino; Antonio Belli
Journal:  Neurochem Res       Date:  2015-04-22       Impact factor: 3.996

5.  GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

Authors:  Linda Papa; Salvatore Silvestri; Gretchen M Brophy; Philip Giordano; Jay L Falk; Carolina F Braga; Ciara N Tan; Neema J Ameli; Jason A Demery; Neha K Dixit; Matthew E Mendes; Ronald L Hayes; Kevin K W Wang; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2014-09-12       Impact factor: 5.269

6.  αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.

Authors:  Stefania Mondello; Steven A Robicsek; Andrea Gabrielli; Gretchen M Brophy; Linda Papa; Joseph Tepas; Claudia Robertson; Andras Buki; Dancia Scharf; Mo Jixiang; Linnet Akinyi; Uwe Muller; Kevin K W Wang; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

7.  Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury.

Authors:  Hanuma Kumar Karnati; Joseph H Garcia; David Tweedie; Robert E Becker; Dimitrios Kapogiannis; Nigel H Greig
Journal:  J Neurotrauma       Date:  2018-10-25       Impact factor: 5.269

8.  In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.

Authors:  Linda Papa; Manoj K Mittal; Jose Ramirez; Michelle Ramia; Sara Kirby; Salvatore Silvestri; Philip Giordano; Kurt Weber; Carolina F Braga; Ciara N Tan; Neema J Ameli; Marco Lopez; Mark Zonfrillo
Journal:  J Neurotrauma       Date:  2015-06-03       Impact factor: 5.269

9.  Peripheral markers of brain damage and blood-brain barrier dysfunction.

Authors:  Nicola Marchi; Peter Rasmussen; Miranda Kapural; Vince Fazio; Kelly Kight; Marc R Mayberg; Andrew Kanner; Barbara Ayumar; Ben Albensi; Marco Cavaglia; Damir Janigro
Journal:  Restor Neurol Neurosci       Date:  2003       Impact factor: 2.406

Review 10.  Reliability of S100B in predicting severity of central nervous system injury.

Authors:  Stephen M Bloomfield; James McKinney; Les Smith; Jonathan Brisman
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.